Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for Neurogene (NGNE) over the last 3 years, with Q3 2025 value amounting to $9.4 million.

  • Neurogene's Accumulated Expenses fell 971.45% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 971.45%. This contributed to the annual value of $9.7 million for FY2024, which is 4437.84% down from last year.
  • Latest data reveals that Neurogene reported Accumulated Expenses of $9.4 million as of Q3 2025, which was down 971.45% from $9.1 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Accumulated Expenses registered a high of $17.5 million during Q4 2023, and its lowest value of $6.8 million during Q1 2024.
  • Moreover, its 3-year median value for Accumulated Expenses was $9.3 million (2025), whereas its average is $9.6 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 4437.84% in 2024, then soared by 2733.76% in 2025.
  • Neurogene's Accumulated Expenses (Quarter) stood at $17.5 million in 2023, then crashed by 44.38% to $9.7 million in 2024, then decreased by 3.15% to $9.4 million in 2025.
  • Its last three reported values are $9.4 million in Q3 2025, $9.1 million for Q2 2025, and $6.8 million during Q1 2025.